232 related articles for article (PubMed ID: 17307347)
1. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP.
Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R
Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347
[TBL] [Abstract][Full Text] [Related]
2. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
4. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
5. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
6. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.
Dinser R; Zaucke F; Kreppel F; Hultenby K; Kochanek S; Paulsson M; Maurer P
J Clin Invest; 2002 Aug; 110(4):505-13. PubMed ID: 12189245
[TBL] [Abstract][Full Text] [Related]
7. Role of TSP-5/COMP in pseudoachondroplasia.
Posey KL; Hayes E; Haynes R; Hecht JT
Int J Biochem Cell Biol; 2004 Jun; 36(6):1005-12. PubMed ID: 15094116
[TBL] [Abstract][Full Text] [Related]
8. MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures.
Roman-Blas J; Dion AS; Seghatoleslami MR; Giunta K; Oca P; Jimenez SA; Williams CJ
J Cell Physiol; 2010 Sep; 224(3):817-26. PubMed ID: 20578249
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
[TBL] [Abstract][Full Text] [Related]
10. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
Chen TL; Posey KL; Hecht JT; Vertel BM
J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
[TBL] [Abstract][Full Text] [Related]
11. A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis.
Hansen U; Platz N; Becker A; Bruckner P; Paulsson M; Zaucke F
Arthritis Rheum; 2011 Jan; 63(1):159-67. PubMed ID: 20936634
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues.
Hecht JT; Deere M; Putnam E; Cole W; Vertel B; Chen H; Lawler J
Matrix Biol; 1998 Aug; 17(4):269-78. PubMed ID: 9749943
[TBL] [Abstract][Full Text] [Related]
13. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.
Hashimoto Y; Tomiyama T; Yamano Y; Mori H
Am J Pathol; 2003 Jul; 163(1):101-10. PubMed ID: 12819015
[TBL] [Abstract][Full Text] [Related]
14. Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion.
Schmitz M; Becker A; Schmitz A; Weirich C; Paulsson M; Zaucke F; Dinser R
J Biol Chem; 2006 Oct; 281(43):32587-95. PubMed ID: 16928687
[TBL] [Abstract][Full Text] [Related]
15. Pseudoachondroplastic dysplasia: an Iowa review from human to mouse.
Stevens JW
Iowa Orthop J; 1999; 19():53-65. PubMed ID: 10847517
[TBL] [Abstract][Full Text] [Related]
16. Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments.
Unger S; Hecht JT
Am J Med Genet; 2001; 106(4):244-50. PubMed ID: 11891674
[TBL] [Abstract][Full Text] [Related]
17. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
18. Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.
Merritt TM; Bick R; Poindexter BJ; Alcorn JL; Hecht JT
Am J Pathol; 2007 Jan; 170(1):293-300. PubMed ID: 17200202
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
20. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
